Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion

Ouyang G, Shu P, Xue Y, Luo F, Li Y

OncoTargets and Therapy 2024, 17:79-84

Published Date: 30 January 2024